Addyi, a non-hormonal prescription tablet, is designed to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Taken daily at bedtime, it helps restore low sexual desire not caused by other medical conditions. Women experiencing persistent distress from lack of interest may benefit from this FDA-approved option.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends